ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
CHMP recommend white blood cell growth stimulator biosimilar to EMA
pharmafile
July 31, 2018The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of two separate biosimilar versions of California-based biopharmaceutical company, Amgen’s Neulasta (pegfilgrastim).
Pharma Sources Insight January 2025
